Section Arrow
Quote
MAZE.NASDAQ
- Maze Therapeutics Inc
Quotes are at least 15-min delayed:2026/08/07 13:47 EDT
Regular Hours
Last
 28.05
-0.48 (-1.68%)
Day High 
29 
Prev. Close
28.53 
1-M High
33.4999 
Volume 
260.56K 
Bid
27.98
Ask
28.11
Day Low
27.445 
Open
28.67 
1-M Low
25.85 
Market Cap 
1.58B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 27.74 
20-SMA 28.28 
50-SMA 27.41 
52-W High 53.65 
52-W Low 12.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.35/-3.51
Enterprise Value
1.60B
Balance Sheet
Book Value Per Share
6.17
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CELZCreative Medical Technology Holdings1.3582+0.2082+18.10%-- 
IOVAIovance Biotherapeutics6.145-0.065-1.05%-- 
ARDXArdelyx4.015-0.855-17.56%-- 
ENSCEnsysce Biosciences0.5135-0.0108-2.06%-- 
ALXOALX Oncology Holdings2.095-0.015-0.71%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM,diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.